SCHEDULE 13G 0001562230 XXXXXXXX LIVE Common Stock 06/30/2025 0001612042 Ascendis Pharma AS 04351P101 TUBORG BOULEVARD 12 HELLERUP G7 NA Rule 13d-1(b) Capital International Investors DE 3099512 0 3109225 0 3109225.00 5.6 IA Ascendis Pharma AS TUBORG BOULEVARD 12, HELLERUP, Denmark Capital International Investors 333 South Hope Street, 55th Fl, Los Angeles, CA 90071 N/A N IA 3,109,225 ** **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 3,109,225 shares or 5.6% of the 55,754,437 shares believed to be outstanding. Shares reported include 3,109,225 Depository Receipts, which represent 3,109,225 Common Stock. 5.6 3,099,512 0 3,109,225 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Capital International Investors Jae Won Chung 08/12/2025